Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03233581 · ClinicalTrials.gov registry record · NA
Improving Physical Activity in Young Adult Cancer Survivors
A NA study, sponsored by Seattle Children's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT03233581 is a NA study that has completed, run by Seattle Children's Hospital. The registered enrollment target is 50 participants.
The verdict
NCT03233581, a NA study, has completed, sponsored by Seattle Children's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
The Primary Goal is to conduct a 12 week pilot randomized controlled trial (RCT) of the Fitbit Flex, a popular, affordable, wearable physical activity tracking device, and the Fitbit mobile health (mHealth) app. The target population will be cancer survivors 18-39 years old recruited from the Seattle Cancer Care Alliance. For the intervention group, peer influences will be engaged via a private, social network (e.g. a Facebook group) customized for survivors. Measurements will be completed (1) at baseline, prior to randomization, and (2) during the final week of the intervention period (follow-up measure). This pilot study will provide initial proof of concept and allow for further customization of the intervention for cancer survivors in anticipation of a future, larger proposal to study physical activity and related outcomes over a multi-year period. Besides conducting exploratory analyses of primary and secondary outcomes for this pilot RCT, we also specify feasibility criteria including: (1) recruiting 50 cancer survivors ages 18-39 years and between 1.0-5.0 years from the completion of active cancer therapy, (2) intervention participants wear the Fitbit Flex on the majority of all intervention days during the 12-week intervention period, and (3) ≥75% of all participants complete online questionnaire data collection at Time 1 and Time 2.
Interventions
- BEHAVIORAL Fitbit + Facebook + Coaching Group
- BEHAVIORAL Fitbit only
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2017-09-12 |
| Est. Completion | 2018-05-22 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03233581
The ClinicalTrials.gov registry entry for NCT03233581 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Seattle Children's Hospital, which has 168 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Fitbit + Facebook + Coaching Group is the first listed.
NCT03233581 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03233581 about?
NCT03233581 is a clinical study titled "Improving Physical Activity in Young Adult Cancer Survivors". The Primary Goal is to conduct a 12 week pilot randomized controlled trial (RCT) of the Fitbit Flex, a popular, affordable, wearable physical activity tracking device, and the Fitbit mobile health (mHealth) app. The target population will be cancer survivors 18-39 years old recruited from the Seattl...
What is the current status of trial NCT03233581?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2017-09-12. Estimated completion is 2018-05-22.
What interventions are being tested in trial NCT03233581?
The interventions under investigation include: Fitbit + Facebook + Coaching Group (BEHAVIORAL), Fitbit only (BEHAVIORAL).
Who is sponsoring clinical trial NCT03233581?
This trial is sponsored by Seattle Children's Hospital, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.